Growing scope of Oregon psilocybin program raises safety concerns, study says

[dpibel]

1. That headline is a bit...highsterical

Actual quote from the Johns Hopkins guy:

David Yaden, an associate professor of psychedelic research at Johns Hopkins University School of Medicine, said the program’s “risk profile” was better than he expected, pointing to a low number of reported negative responses involving psilocybin. But he said that there is still a possibility that concerns are not being fully reported.

“Some people reported seeking out psychedelic services for general well-being while others reported seeking out services to treat medical or psychiatric conditions,” he wrote in an email. “There is some ambiguity about whether the services were designed to support these kinds of medical treatment related reasons, and this is an area for further discussion and consideration on the policy level.”

Not exactly the words of a person sounding the alarm klaxon.

(No knock on the OP; that's the hed the website gave the article.)